Jonas Persson Reflects on 2024: A Year of Resilience and Opportunity for Rosti Group

As we begin 2025, it’s a good moment to reflect on how far Rosti Group has come over the past 12 months. I feel that the year has centred on adaptability, innovation and collaboration.

Coming into 2024 on the back of a challenging 2023, we remained focused on our growth strategy whilst also being mindful of the previous 12 months which saw volumes decline across the industry.

The first half of 2024 was particularly strong for Rosti. We saw a significant improvement in market confidence and successfully picked up momentum. While many smaller competitors struggled to keep pace with the evolving market landscape, our ability to support customers early in their product development journey has proved vital.

Geopolitical events, such as the U.S. election, has led to uncertainties in some sectors and regions, not to mention questions being posed in markets such as China.

However, these challenges only underscore the importance of having a strong, global footprint. As a company with operations spanning Europe, North America, and Asia, we are well-positioned to help customers navigate these uncertain times.

By focusing on what we do best—delivering quality, innovative, and sustainable injection moulding and contract manufacturing solutions.

Read the full article here -

Rosti Asia’s Strategic Expansion into India: Driving Growth in a Dynamic Market

Pat Williams, Senior Vice President Asia, shares his insight on Rosti Asia's expansion into India, the growth strategy and what it means for our customers.?

In 2025, Rosti Group will open a new facility in Chennai, India, marking a major step in expanding our global presence. This new facility underscores our strategic commitment to growing operations across Asia and presents an exciting opportunity for our division and the wider Rosti Group.

It will complement our existing Asian sites in China and Malaysia, enhancing our ability to support customers and meet the increasing demand in the region.

Discover more about our Rosti Asia strategy -

Supporting the Medical Industry in Limiting Time-to-Market through Innovation Capabilities and 72-Hour Concept-to-Reality Process

In the fast-paced world of medical device manufacturing, time to market is a decisive factor for success. The ability to design, manufacture, and deliver new medical devices at speed is crucial from the perspective of having an impact on patients, meeting regulatory requirements and the commercial success of a device.

Through our state-of-the-art Innovation Centres and unrivalled 72-hour concept-to-reality process, we collaborate with our medical customers to meet the critical demands of speed, precision, and innovation.

Rosti Group Partners with Axis Technology to Identify 24% Energy Reduction Across Global Sites

Through our partnership with Axis Technology, renowned experts in energy efficiency and sustainability, Rosti Group have conducted a thorough Energy Efficiency Assessment, to help implement a comprehensive energy-saving measures across our global footprint.

This collaboration has led to us identifying opportunities to reduce energy consumption by 24%, demonstrating the effectiveness of targeted energy efficiency measures.

Learn more about our partnership -